drugset / Trial / NCT00281320

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

NCT00281320

Phase 3 Completed 122 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the safety and tolerability of Asenapine in elderly patients with psychosis.

Timeline

Start
2006-02
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Asenapine Other / unclassified 10 mg Subcutaneous

Indications